SMART Base
0.2.0 - ci-build
SMART Base, published by WHO. This guide is not an authorized publication; it is the continuous build for version 0.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/smart-base/tree/main and changes regularly. See the Directory of published versions
Built from commit d97caff5.
| Draft as of 2026-03-20 |
<ActorDefinition xmlns="http://hl7.org/fhir">
<id value="SGAuthoring.Persona.ClinicalSME"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><div xml:lang="en" lang="en"><hr/><p><b>English</b></p><hr/><p class="res-header-id"><b>Generated Narrative: ActorDefinition SGAuthoring.Persona.ClinicalSME</b></p><a name="SGAuthoring.Persona.ClinicalSME"> </a><a name="hcSGAuthoring.Persona.ClinicalSME"> </a><table class="grid"><tr><td><b>Actor: ClinicalSME </b></td><td>Clinical Subject Matter Expert</td><td>Type: person </td></tr><tr><td colspan="3"/></tr></table></div><div xml:lang="fr" lang="fr"><hr/><p><b>French</b></p><hr/><p class="res-header-id"><b>Narratif généré : ActorDefinition SGAuthoring.Persona.ClinicalSME</b></p><a name="fr-SGAuthoring.Persona.ClinicalSME"> </a><a name="fr-hcSGAuthoring.Persona.ClinicalSME"> </a><table class="grid"><tr><td><b>Acteur : ClinicalSME </b></td><td>Clinical Subject Matter Expert</td><td>Type : person </td></tr><tr><td colspan="3"/></tr></table></div><div xml:lang="ar" lang="ar"><hr/><p><b>Arabic</b></p><hr/><p class="res-header-id"><b>السرد المُنشأ: ActorDefinition SGAuthoring.Persona.ClinicalSME</b></p><a name="ar-SGAuthoring.Persona.ClinicalSME"> </a><a name="ar-hcSGAuthoring.Persona.ClinicalSME"> </a><table class="grid"><tr><td><b>Project-Id-Version: FHIR
Report-Msgid-Bugs-To: you@example.com
POT-Creation-Date: 2025-07-19 23:19+0000
PO-Revision-Date: 2025-07-19 23:19+0000
Language: ar
MIME-Version: 1.0
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: 8bit </b></td><td>Clinical Subject Matter Expert</td><td>اكتب: person </td></tr><tr><td colspan="3"/></tr></table></div><div xml:lang="zh" lang="zh"><hr/><p><b>Chinese</b></p><hr/><p class="res-header-id"><b>Generated Narrative: ActorDefinition SGAuthoring.Persona.ClinicalSME</b></p><a name="zh-SGAuthoring.Persona.ClinicalSME"> </a><a name="zh-hcSGAuthoring.Persona.ClinicalSME"> </a><table class="grid"><tr><td><b>Actor: ClinicalSME </b></td><td>Clinical Subject Matter Expert</td><td>Type: person </td></tr><tr><td colspan="3"/></tr></table></div><div xml:lang="ru" lang="ru"><hr/><p><b>Russian</b></p><hr/><p class="res-header-id"><b>Сгенерированный нарратив: ActorDefinition SGAuthoring.Persona.ClinicalSME</b></p><a name="ru-SGAuthoring.Persona.ClinicalSME"> </a><a name="ru-hcSGAuthoring.Persona.ClinicalSME"> </a><table class="grid"><tr><td><b>Актер: ClinicalSME </b></td><td>Clinical Subject Matter Expert</td><td>Тип: person </td></tr><tr><td colspan="3"/></tr></table></div><div xml:lang="es" lang="es"><hr/><p><b>Spanish</b></p><hr/><p class="res-header-id"><b>Generated Narrative: ActorDefinition SGAuthoring.Persona.ClinicalSME</b></p><a name="es-SGAuthoring.Persona.ClinicalSME"> </a><a name="es-hcSGAuthoring.Persona.ClinicalSME"> </a><table class="grid"><tr><td><b>Actor: ClinicalSME </b></td><td>Clinical Subject Matter Expert</td><td>Type: person </td></tr><tr><td colspan="3"/></tr></table></div></div>
</text>
<url
value="http://smart.who.int/base/ActorDefinition/SGAuthoring.Persona.ClinicalSME"/>
<version value="0.2.0"/>
<name value="ClinicalSME"/>
<title value="Clinical Subject Matter Expert"/>
<status value="draft"/>
<experimental value="true"/>
<date value="2026-03-20T00:42:00+00:00"/>
<publisher value="WHO"/>
<contact>
<name value="WHO"/>
<telecom>
<system value="url"/>
<value value="http://who.int"/>
</telecom>
</contact>
<description
value="A clinician or subject matter expert (SME) of a specific health area who
validates the clinical accuracy and completeness of DAK content against
WHO guidelines and other normative products. SMEs should be the authors
of the source documents or recognized experts actively engaged in, if not
leading, the collaborative development of the DAKs.
Key activities:
- Validate that DAK components accurately reflect L1 recommendations
- Provide clinical ground-truthing through country visits and interviews
- Identify gaps or needed changes in DAK content
- Review decision-support logic for clinical correctness
- Confirm that workflows represent 80% of clinical scenarios
- Validate personas against real-world practice settings
- Advise on cross-programme overlaps (e.g. TB/HIV indicators)
**Source**: IG Starter Kit, L2 DAK Authoring, Sections 1 "Plan" and 2.2 "Validate""/>
<type value="person"/>
</ActorDefinition>